According to the report by Expert Market Research (EMR), the global erythropoietin drugs market size attained a value of USD 10.3 billion in 2023. Aided by the growing demand for effective anaemia treatments and the increasing applications of erythropoietin drugs in multiple sectors, the market is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032 to attain a value of USD 17 billion by 2032.
Erythropoietin is a hormone produced by the kidneys that plays a pivotal role in the production of red blood cells. Pharmaceutical versions of this hormone, known as erythropoietin drugs, are commonly employed to treat anaemia, especially in patients suffering from chronic kidney disease and cancer. The drugs are instrumental in promoting red blood cell production, enhancing oxygen supply, and improving the overall health of patients. In addition to their medicinal properties, erythropoietin drugs are utilised for their performance-enhancing properties in competitive sports, although such use is generally considered illegal and unethical.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/erythropoietin-drugs-market/requestsample
The rising demand for effective anaemia treatments is the key driver for the global erythropoietin drugs market growth. With an increase in awareness about the risks associated with anaemia and the health benefits of maintaining healthy red blood cell counts, there is a noticeable shift towards the adoption of erythropoietin drugs. This trend is leading to a surge in demand for these pharmaceuticals. Additionally, the escalating global prevalence of chronic diseases such as kidney disease and cancer is further bolstering the demand for erythropoietin drugs.
The broadening application of erythropoietin drugs in various sectors is also significantly contributing to the erythropoietin drugs market expansion. In the healthcare industry, these drugs are not only used for treating anaemia but also increasingly considered for their potential benefits in conditions like heart disease and stroke. Furthermore, the development of novel erythropoietin drugs with fewer side effects and enhanced efficacy offers new opportunities for erythropoietin drugs market development.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/erythropoietin-drugs-market
Further, the growing investment in research and development activities within the pharmaceutical industry has led to an increased focus on erythropoietin drugs as promising therapeutics. The advancements in biotechnology and the emergence of biosimilars have resulted in the development of more effective and affordable erythropoietin drugs, thereby propelling the erythropoietin drugs market growth.
Erythropoietin Drugs Market Segmentation
The market can be divided based on drug type, product type, application, end user, and region.
Market Breakup by Drug Type
- Biologics
- Biosimilars
Market Breakup by Product Type
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin-alfa
- Others
Market Breakup by Application
- Haematology
- Kidney Disorder
- Cancer
- Others
Market Breakup by End User
- Hospitals
- Homecare
- Speciality Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global erythropoietin drugs companies. Some of the major key players explored in the report by Expert Market Research are as follows:
- Amgen Inc.
- Biocon Limited
- Reddy’s Laboratories Ltd.
- Hoffmann-La Roche AG
- Intas Pharmaceuticals Ltd.
- Johnson & Johnson
- LG Chem Ltd.
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
